Background: Previous medical history strongly contributes to the genesis of intracranial
aneurysms (IA). A possible impact of regular medication on the occurrence of abdominal …

Background and purpose Hypertension is a risk factor for subarachnoid hemorrhage and is
also considered a risk factor for saccular intracranial aneurysm (sIA) formation. However …

Background and purpose Establishment of drug therapy to prevent rupture of unruptured
intracranial aneurysms (IAs) is needed. Previous human and animal studies have gradually …

Background and Purpose—Three percent of the population has an unruptured intracranial
aneurysm (UIA). We aimed to identify independent risk factors from lifestyle and medical …

Background Conflicting findings exist on the protective role of aspirin against aneurysmal
subarachnoid hemorrhage (SAH). In this retrospective analysis, we compare the risk of SAH …

Intracranial aneurysms (IA) are a relatively frequent vascular abnormality. The prevailing
opinion is that cerebral aneurysmal disease is related to hemodynamic and genetic factors …

Patient-related, modifiable risk factors—in addition to arterial hypertension, established in
PHASES—are current cigarette smoking and heavy alcohol consumption. 14, 15 For …

Background and aims: The role of statins in unruptured intracranial aneurysm (UIA) growth
and rupture remains ambiguous. This study sought to determine whether atorvastatin is …

2592 Stroke September 2019 it was observed that ASA usage alone for> 3 years was
associated with decreased odds of SAH (OR, 0.63; 95% CI, 0.45–0.90). No statistically …

Objectives Aspirin has been suggested as a potential therapeutic strategy to prevent the
growth and rupture of unruptured intracranial aneurysms (UIAs), but there is still controversy …